104 related articles for article (PubMed ID: 22366562)
1. Telomere length and regulatory proteins in human skeletal muscle with and without ongoing regenerative cycles.
Ponsot E; Echaniz-Laguna A; Delis AM; Kadi F
Exp Physiol; 2012 Jun; 97(6):774-84. PubMed ID: 22366562
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
5. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of protein binding to telomeres in living cells: implications for telomere structure and function.
Mattern KA; Swiggers SJ; Nigg AL; Löwenberg B; Houtsmuller AB; Zijlmans JM
Mol Cell Biol; 2004 Jun; 24(12):5587-94. PubMed ID: 15169917
[TBL] [Abstract][Full Text] [Related]
7. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation.
Muramatsu Y; Tahara H; Ono T; Tsuruo T; Seimiya H
Exp Cell Res; 2008 Mar; 314(5):1115-24. PubMed ID: 18221737
[TBL] [Abstract][Full Text] [Related]
8. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
9. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
10. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
[TBL] [Abstract][Full Text] [Related]
11. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
[TBL] [Abstract][Full Text] [Related]
12. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex.
Ye JZ; de Lange T
Nat Genet; 2004 Jun; 36(6):618-23. PubMed ID: 15133513
[TBL] [Abstract][Full Text] [Related]
13. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
14. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
15. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
16. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
17. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
18. Increased shelterin mRNA expression in peripheral blood mononuclear cells and skeletal muscle following an ultra-long-distance running event.
Laye MJ; Solomon TP; Karstoft K; Pedersen KK; Nielsen SD; Pedersen BK
J Appl Physiol (1985); 2012 Mar; 112(5):773-81. PubMed ID: 22162529
[TBL] [Abstract][Full Text] [Related]
19. PTOP interacts with POT1 and regulates its localization to telomeres.
Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
[TBL] [Abstract][Full Text] [Related]
20. The effects of regular strength training on telomere length in human skeletal muscle.
Kadi F; Ponsot E; Piehl-Aulin K; Mackey A; Kjaer M; Oskarsson E; Holm L
Med Sci Sports Exerc; 2008 Jan; 40(1):82-7. PubMed ID: 18091019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
